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CORRESPONDENCE OPEN
Have rates of readmission for COPD been overestimated?
npj Primary Care Respiratory Medicine (2016) 26, 16066;
doi:10.1038/npjpcrm.2016.66; published online 13 October 2016
Hospital admissions and readmissions for chronic obstructive
pulmonary disease (COPD) have been regarded as avoidable.1 In
npjPCRM we reported on the stability of annual English national
COPD admission data (2001–2010) presented as rates per 10,000
patients on a general practice list.2 Using these data we have
derived national rates of COPD readmissions associated with these
admissions. The derived COPD readmission rates are in keeping
with other international studies.3,4 They stand in contrast to UK
COPD readmission rates reported by the Royal College of
Physicians (RCP) in 1997, 2003, 2008 and 2013. In this letter we
compare the two approaches.
In their audits the RCP combined prospective identiﬁcation of
patients admitted with COPD with retrospective analysis of the
outcome of that admission.5–7 Ninety days after admission, overall
mortality was reported as 14.0% and readmission rate was
31–34%.5,8 The ﬁndings have led to a raft of recommendations
encompassing all aspects of COPD care and including detailed
discharge care bundles.7 We believe ﬂaws in the method of the
RCP Audit surveys make their ﬁndings unrepresentative of COPD
admissions, and tend to undermine the evidence for their
recommendations.
The RCP audits aimed to prospectively identify patients
admitted with COPD. They speciﬁcally excluded patients in whom
the diagnosis of COPD was applied after the initial assessment.5
This exclusion is likely to have skewed enrolment towards those
patients at the most severe end of the COPD spectrum who would
have been more easily identiﬁed on admission. Only 7% of
patients in the latest RCP COPD audit were not known previously
to have had COPD.7 There is considerable diagnostic uncertainty
upon admission of a patient with worse breathlessness, sputum
volume or sputum purulence to an Emergency Department or
Medical Admissions Unit.9,10 This particularly affects the attribu-
tion of cause in a patient without a previous COPD diagnosis. A
ﬁrst admission is often the point of deﬁnitive diagnosis of COPD.
The preferential inclusion of patients, the vast majority of whom
were known previously to have had COPD, is suggestive of the
probable greater severity of this group. They would have had an
exceptional risk of readmission within 90 days and a low likelihood
that they were representative of all COPD admissions. It is not
speciﬁed whether only readmissions for COPD were included in
the RCP audits, but the analysis and interpretation of all four
audits imply that the readmission analysis was of COPD only.
The study we reported in the npjPCRM was based on COPD
admissions reported by the NHS Information Centre Hospital
Episodes Statistics database.2 Admission data were obtained for a
sample of 806 English general practices that were representative
of national practices in terms of COPD prevalence and deprivation
score. The registered practice was recorded for every admitted
patient. Every COPD admission was coded with the patient’s
unique NHS number, enabling calculation of both the overall
annual COPD admission rate and the annual rate of patients
admitted with COPD per 10,000 patients on the GP list. These rates
allowed calculation of the maximum annual COPD readmission
rate per patient. Between 2001 and 2010, the mean annual
number of patients admitted with COPD/10,000 patients ranged
from 15.7 to 19.3, a variation of 22.9%. The mean annual number
of COPD admissions/10,000 patients ranged from 24.3 to 28.3, a
variation of 16.5%. Graphical representation of these rates with
95% conﬁdence intervals demonstrated their relative stability.2
The denominator used, rates per 10,000 patients on a general
practice list, enabled expression of the admission rate with relative
conﬁdence. More than 97% of the population in England is
registered with a general practitioner with little duplicate
registration.11
The npjPCRM paper shows that the annual difference between
the rate of patients admitted with COPD and the overall rate of
COPD admissions ranged between 2001 and 2010 from 6.1 (2008)
to 10.1 (2003) COPD admissions/10,000 patients.2 This difference
represents the excess of COPD admissions over the number of
patients admitted with COPD. This excess is the rate of COPD
readmissions within the year. On the basis of these data we have
calculated readmission rates in this nationally representative
sample. There were between 0.316 [6.1/19.3—the ratio in 2008]
and 0.555 [10.1/18.2—the ratio in 2003] readmissions per patient
per year, a range of one readmission per 8–14% of patients per
quarter. This range is between a third and a half of the rate
reported in the RCP audit.
The relatively low COPD readmission rates that we are
reporting, allied to the long-term stability of COPD admissions,
calls into question the validity of using COPD readmissions as a
marker of quality of care. These ﬁndings together with our
previous observations on the lack of evidence for an effect of
primary care interventions on COPD admission risk emphasises
the importance of directing efforts towards primary prevention of
COPD and smoking cessation.12
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